Products Enoxacin is commercially available in the form of film-coated tablets (Enoxor). The drug is not registered in many countries. Structure and properties Enoxacin (C15H17FN4O3, Mr = 320.3 g/mol) is a fluoroquinolone. Effects Enoxacin (ATC J01MA04) has bactericidal properties. The effects are due to inhibition of bacterial DNA gyrase. Indications For the treatment of infections … Enoxacin
Products Nadifloxacin is commercially available as a cream (Nadixa). The drug is not registered in many countries. It has been approved in Japan since 1993 and in Germany since 2000. Structure and properties Nadifloxacin (C19H21FN2O4, Mr = 360.4 g/mol) is a 3rd generation fluoroquinolone. The figure shows the more active -nadifloxacin; the cream contains the … Nadifloxacin
Products Finafloxacin was approved in the United States in 2015 in the form of ear drops (Xtoro). The drug has not yet been registered in many countries. Structure and properties Finafloxacin (C20H19FN4O4, Mr = 398.4 g/mol) is a fluoroquinolone. It exists as a white to yellow powder or crystals and is sparingly soluble in water. … Finafloxacin
Products Orbifloxacin was commercially available in the form of film-coated tablets for animals (Orbax, out of commerce in many countries), among other products. It is also used as a combination preparation in the form of ear drops (Posatex). Structure and properties Orbifloxacin (C19H20F3N3O3, Mr = 395.4 g/mol) is a fluoroquinolone. Effects Orbifloxacin (ATCvet QJ01MA95) has … Orbifloxacin
Products Danofloxacin is commercially available as a solution for injection as a veterinary drug. It has been approved in many countries since 1996. Structure and properties Danofloxacin (Mr = 357.4 g/mol, C19H20FN3O3) is a fluoroquinolone. Effects Danofloxacin (ATCvet QJ01MA92) is antibacterial against Gram-positive and Gram-negative pathogens. The effects are due to inhibition of bacterial DNA … Danofloxacin
Products Difloxacin is commercially available in tablet form (Dicural). It has been approved in many countries since 1997. Structure and properties Difloxacin (C21H19F2N3O3, Mr = 399.4 g/mol) is a fluoroquinolone. Effects Difloxacin (ATCvet QJ01MA94) is bactericidal. Indications For the treatment of urinary tract, respiratory tract, skin, and soft tissue infections in dogs.
Products Norfloxacin is commercially available in the form of film-coated tablets. It was approved in many countries in 1983. The original product, Noroxin, is no longer available, but generics are available. Structure and properties Norfloxacin (C16H18FN3O3, 319.33 g/mol) is a fluoroquinolone. It exists as a white to pale yellow, hygroscopic, photosensitive crystalline powder that is … Norfloxacin
Products Pradofloxacin is commercially available in the form of tablets for dogs and cats. It has been approved in many countries since 2012. Structure and properties Pradofloxacin (C21H21FN4O3, Mr = 396.4 g/mol) is a fluoroquinolone. Effects Pradofloxacin (ATCvet QJ01MA97) has bactericidal properties. The effects are due to inhibition of bacterial DNA gyrase and topoisomerase IV. … Pradofloxacin
Tavanic® is a prescription drug and may only be used on the doctor’s instructions. Tavanic® contains the active ingredient levofloxacin and is an antibiotic. It belongs to the antibiotic group of fluoroquinolones and is used against bacterial infections. Tavanic® (or Levofloxacin) works by both inhibiting the growth of bacteria and killing them. It inhibits the … Tavanic®
